参考文献/References:
[1] Khalili-Azad T,Razmkhah M,Ghiam AF,et al.Association of interleukin-18 gene promoter polymorphisms with breast cancer[J].Neoplasma,2009,56(1):22-25.
[2] Taheri M,Hashemi M,Eskandari-Nasab E,et al.Association of -607 C/Apolymorphism of IL-18 gene(rs1946518)with breast cancer risk in Zahedan,Southeast Iran[J].Prague Med Rep,2012,113(3):217-222.
[3] Back LK,Farias TD,da Cunha PA,et al.Functional polymorphisms of interleukin-18 gene and risk of breast cancer in a Brazilian population[J].Tissue Antigens,2014,84(2):229-233.
[4] Okamura H,Tsutsi H,Komatsu T,et al.Cloning of a new cytokine that induces IFN-gamma production by T cells[J].Nature,1995,378(6552):88-91.
[5] Yang Y,Cheon S,Jung MK,et al.Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPKpathway[J].Biochem Biophys Res Commun,2015,459(3):379-386.
[6] Liu X,Hu J,Sun S,et al.Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro[J].Exp Ther Med,2015,9(4):1192-1200.
[7] Qi YY,Lu C,Ju Y,et al.Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells[J].Asian Pac J Cancer Prev,2014,15(18):7857-7861.
[8] Chen ZF,Zhou R,Xia B,et al.Interleukin-18 and -12 synergistically enhance cytotoxic functions of tumor-infiltrating lymphocytes[J].Chin Med J(Engl),2012,125(23):4245-4248.
[9] Tse BW-c,Russell PJ,Lochner M,et al.IL-18 inhibits growth of murineorthotopic prostate carcinomas via both adaptive and innate immune mechanisms[J].PLoS One,2011,6(9):e24241.
[10] Sun S,Liu X,Jiang D,et al.Effect of interleukin-18 gene modified human umbilical cord mesenchymal stem cells on proliferation of breast cancer cell[J].Notional Medical Journal of China,2014,94(26):2013-2017.
[11] Yoon DY,Cho YS,Park JW,et al.Up-regulation of reactive oxygen species(ROS)and resistance to Fas-mediated apoptosis in the C33A cervical cancer cell line transfected with IL-18 receptor[J].Clin Chem Lab Med,2004,42(5):499-506.
[12] Kim KE,Song H,Kim TS,et al.Interleukin-18 is a critical factor forvascular endothelial growth factor-enhanced migration in human gastric cancer cell lines[J].Oncogene,2007,26(10):1468-1476.
[13] Yang Y, Cheon S, Jung MK, et al.Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway[J].Biochem Biophys Res Commun,2015,459(3):379-386.
[14] Jiang DF,Liu WL,Lu YL,et al.Function of IL-18 in promoting metastasis of lung cancer[J].Chinses Journal of Oncology,2003,25(4):348-352.
[15] Terme M,Ullrich E,Armeic L,et al.IL-18 induces PD-1-dependent immunosuppression in cancer[J].Cancer Research,2011,71(16):5393-5399.
[16] Jaiswal PK,Singh V,Srivastava P,et al.Association of IL-12,IL-18variants and serum IL-18 with bladder cancer susceptibility in North Indian population[J].Gene,2013,519(1):128-134.
[17] Singh PK,Ahmad MK,Kumar V,et al.Effects of interleukin-18 promoter(C607A and G137C)gene polymorphisms and their association with oral squamous cell carcinoma(OSCC)in northern India[J].Tumour Biol,2014,35(12):12275-12284.
[18] Tsai HT,Hsin CH,Hsieh YH,et al.Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression[J].PLoS One,2013,8(12):e83572.
相似文献/References:
[1]党小军,张华,王欣.人附睾蛋白4(HE4)在乳腺癌诊断中的价值[J].现代检验医学杂志,2015,30(06):84.[doi:10.3969/j.issn.1671-7414.2015.06.024]
DANG Xiao-jun,ZHANG Hua,WANG Xin.Value of Human Epididymis
Protein 4(HE4) in Diagnosis of Breast Cancer[J].Journal of Modern Laboratory Medicine,2015,30(04):84.[doi:10.3969/j.issn.1671-7414.2015.06.024]
[2]张 萍,任世云,张 雷.乳腺癌患者血清脂质运载蛋白-2
和基质金属蛋白酶-9的表达及临床意义[J].现代检验医学杂志,2015,30(01):72.[doi:10.3969/j.issn.1671-7414.2015.01.019]
ZHANG Ping,REN Shi-yun,ZHANG Lei.Expression and Clinical Significance of Serum LCN-2
and MMP-9 in Patients with Breast Cancer[J].Journal of Modern Laboratory Medicine,2015,30(04):72.[doi:10.3969/j.issn.1671-7414.2015.01.019]
[3]刘延梅,马少君,张月浪,等.人类表皮生长因子受体2在乳腺癌表达与临床的相关病理特征分析[J].现代检验医学杂志,2016,31(05):91.[doi:10.3969/j.issn.1671-7414.2016.05.024]
LIU Yan-mei,MA Shao-jun,ZHANG Yue-lang,et al.Expression of Human Epidermal Growth Factor Receptor 2 and
Correlation with Clinical Pathological Features in Breast Cancer[J].Journal of Modern Laboratory Medicine,2016,31(04):91.[doi:10.3969/j.issn.1671-7414.2016.05.024]
[4]陈雨欣,谭婷婷,宁明哲.乳腺癌患者血清中白介素35(IL-35)的表达及其临床意义[J].现代检验医学杂志,2017,32(02):92.[doi:10.3969/j.issn.1671-7414.2017.02.025]
CHEN Yu-xin,TAN Ting-ting,NING Ming-zhe.Serological Interleukin-35 Level
in Patients with Breast Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(04):92.[doi:10.3969/j.issn.1671-7414.2017.02.025]
[5]唐努尔·艾尔肯,阿孜古·祖农.盐酸罗哌卡因对人乳腺癌细胞运动作用的研究[J].现代检验医学杂志,2017,32(03):128.[doi:10.3969/j.issn.1671-7414.2017.03.035]
TANGNUER·Aierken,AZIGU·Zunong.Study on Effect of Ropivacaine on Migration of Breast Cancer Cell
s[J].Journal of Modern Laboratory Medicine,2017,32(04):128.[doi:10.3969/j.issn.1671-7414.2017.03.035]
[6]靳庆娥,苏建荣.北京地区汉族女性人群SYK基因启动子区-803A>Trs290987单核苷酸多态性与乳腺癌易感性分析[J].现代检验医学杂志,2018,33(02):5.[doi:10.3969/j.issn.1671-7414.2018.02.001]
JIN Qing-e,SU Jian-rong.Associations of SYK Promoter-803A
>T(rs290987)Single Nucleotide Polymorphisms with Susceptibility
to Breast Cancer of Han Female Population in Beijing Area[J].Journal of Modern Laboratory Medicine,2018,33(04):5.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[7]高 华a,李玉柱b,韩龙才c,等.Logistic回归和ROC工作曲线评价联合检测血清CA153,TPS,CYFRA21-1在乳腺癌诊断中的临床价值[J].现代检验医学杂志,2018,33(03):60.[doi:10.3969/j.issn.1671-7414.2018.03.016]
GAO Huaa,LI Yu-zhub,HAN Long-caic,et al.Clinical Value of Logistic Regression and ROC Work Curve Evaluating
Serum CA153,TPS and Cyfra21-1 for Diagnosis of Breast Cancer[J].Journal of Modern Laboratory Medicine,2018,33(04):60.[doi:10.3969/j.issn.1671-7414.2018.03.016]
[8]李 娜a,赵晓娟b,苏晓明a.乳腺组织中SMG-1mRNA和SOX4mRNA检测在乳腺癌监测中的应用[J].现代检验医学杂志,2019,34(02):35.[doi:10.3969/j.issn.1671-7414.2019.02.010]
LI Naa,ZHAO Xiao-juanb,SU Xiao-minga.Application of Detection of SMG-1mRNA and SOX4mRNAin Breast Tissue in Surveillance for Breast Cancer[J].Journal of Modern Laboratory Medicine,2019,34(04):35.[doi:10.3969/j.issn.1671-7414.2019.02.010]
[9]靳庆娥,乌姗娜,张亚鑫,等.血清糖化血红蛋白和CA15-3水平检测与女性乳腺癌发病风险的相关性研究[J].现代检验医学杂志,2019,34(04):143.[doi:10.3969/j.issn.1671-7414.2019.04.035]
JIN Qing-e,WU Shan-na,ZHANG Ya-xin,et al.Relationship of Glycosylated Hemoglobin A1c
and Tumor Marker CA15-3 Levels in Serum
with Breast Cancer Susceptibility in Women of Beijing Area[J].Journal of Modern Laboratory Medicine,2019,34(04):143.[doi:10.3969/j.issn.1671-7414.2019.04.035]
[10]王 碧,吉茂礼.乳腺癌组织长链非编码RNA UCA1和BCAR4表达与辅助化疗效果的相关性研究[J].现代检验医学杂志,2019,34(05):77.[doi:10.3969/j.issn.1671-7414.2019.05.019]
WANG Bi,JI Mao-li.Correlational Research on the Expressionof Long-Chain Non-Coding RNA UCA1 and BCAR4in Breast Cancer Tissues for the Effect of Adjuvant Chemotherapy[J].Journal of Modern Laboratory Medicine,2019,34(04):77.[doi:10.3969/j.issn.1671-7414.2019.05.019]